with which it signed a licensing deal earlier this year to sell its COVID vaccine from 2025 in several markets, including the ...

On 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

Pfizer-BioNTech, Johnson and Johnson, and Moderna said their vaccines prevented severe illness and hospitalization in COVID-19 cases caused by the variant ... in June 2024 and rapidly spread ...

The WHO declared mpox a global public health emergency for the second time in two years in August after a new variant of the ...

An opponent of vaccines who wrote social media posts urging violence against scientists, politicians and public health officials during the COVID-19 pandemic was sentenced Monday to five ...

A significant majority of citizens are heading to pharmacists for the flu vaccine, the COVID-19 vaccine, and colorectal ...

An additional case of a new strain of mpox has been detected in Britain, bringing the total number of infections in the ...

Among the consequences of his term was the U.S.’ high Covid death rate (at least compared with Europe) as Trump abdicated his responsibility ... perhaps the country’s best-known disparager of vaccines ...

Earlier in October, the European Commission approved Novavax's updated 2024-2025 Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2705), dispersion for injection, for use in ...

The WHO also set up a scheme to help bring mpox vaccines, tests and treatments to the most vulnerable people in the world's poorest countries, similar to efforts during the COVID-19 pandemic.